Status:
COMPLETED
Treatment of Peritonitis in Automated Peritoneal Dialysis
Lead Sponsor:
Universidad de Colima
Collaborating Sponsors:
Instituto Mexicano del Seguro Social
Conditions:
Secondary Peritonitis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The main infectious complication of peritoneal dialysis (PD) is bacterial peritonitis, which increases morbidity, mortality and conversion to hemodialysis. In Mexico, 485 patients per million people ...
Detailed Description
GENERAL DESCRIPTION OF THE STUDY. PROCEDURES: Patients with peritonitis (clinical, cytological sample with leukocytes \>100/μL, and \>50% Polymorphonuclear, taken from a dialysis exchange with 2 to ...
Eligibility Criteria
Inclusion
- \> 18 years in Automated Peritoneal Dialysis.
- Patients in the Hospital General 1, 10 and sub-zone 4 of Colima.
- Patients with diagnosis of peritonitis (abdominal pain, fever, vomiting, nausea, turbid fluid, cytologic with leukocytes \>100 cells/mm3, polymorphonuclear \>50%).
- Functional catheter.
- Signed informed consent of acceptance to participate in the study.
Exclusion
- Patients allergic to vancomicyn.
- Patients allergic to ceftazidime.
- Patients with Intestinal perforation.
- Patients with abdominal cavity classified as unfit to PD.
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04077996
Start Date
July 1 2019
End Date
August 30 2022
Last Update
March 26 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hgz 10 Instituto Mexicano Del Seguro Social
Manzanillo, Colima, Mexico, 28100
2
Hgsz 4 Instituto Mexicano Del Seguro Social
Tecomán, Colima, Mexico, 28100
3
Hgz 1 Instituto Mexicano Del Seguro Social
Colima, Mexico, 28979